Capital Wealth Mid-Week Daily — June 12, 2026

Friday's Tape · Markets

Stocks Roar Back: The Dow Jumps Nearly 1,000 Points As Dip-Buyers Return.

A trading floor turning green after a sharp rebound.

The day after the worst session in weeks, buyers came right back. The Dow Jones Industrial Average jumped 929.97 points to 50,848.75 — up 1.86% — with the Nasdaq adding 2.5% and Europe's STOXX 600 up 0.5%. The same names that led Wednesday's inflation selloff led the bounce.

I'll be honest: a one-day rebound this size tells you more about positioning than about fundamentals. Nothing about Wednesday's hot CPI changed overnight; the ‘higher-for-longer’ math is exactly where it was. So I didn't chase the rip. I kept the book where it's been — tilted toward cash-flow — and let the fast money trade the noise.

World · Geopolitics

Trump Threatens To Strike Iran's Oil — And Crude Catches A Bid.

An oil tanker at dusk as Gulf tensions rise.

President Trump escalated again, threatening further military strikes on Iran and floating the idea of seizing its oil infrastructure. Energy traders did what energy traders do when the Strait of Hormuz is in the headlines — they bid crude up.

This is exactly why I've kept an energy and defense sleeve through a year when it wasn't fashionable. Oil is the cleanest hedge against precisely this kind of headline, and the defense names benefit from a world that keeps re-arming. I'm not adding on the threat — I already own the insurance.

Special Report · Markets

SpaceX Goes Public In The Largest IPO Ever — And Pops 19%.

A rocket on the pad at dawn as SpaceX debuts.

SpaceX (SPCX) debuted at roughly a $1.75 trillion valuation — the largest initial public offering in history — and the stock popped about 19% to $161 on its first day. Starlink, now past 10 million subscribers, is the cash engine underneath it.

I wrote a full piece on why I think SpaceX rhymes with the automobile and AI revolutions — a platform shift, not a stock story — and why we don't chase day-one pops. Read the full Special Report →

Health · Your Money

The Nursing-Home Coin Flip: Medicare Advantage Denials Draw A Federal Probe.

A quiet hospital corridor; care that may or may not be covered.

A new federal investigation found that Medicare Advantage insurers — including CVS Health's Aetna (CVS), Humana (HUM), Cigna (CI) and others — deny skilled-nursing and inpatient-rehab stays at strikingly high rates, in some cases as high as 80%, often reversing them only on appeal.

For the teachers and public-sector retirees I work with, this is the most important story in the paper today — and it has nothing to do with the stock market. The Medicare Advantage vs. traditional Medicare decision quietly determines whether the care you paid for your whole life is actually there when you need it. If you're near 65, let's talk about it before open enrollment, not after.

Business · Profile

From Sizzler To SpaceX: The Quiet Billionaire Behind Musk's Empire.

A boardroom at dusk; quiet money behind a famous name.

The Journal profiled Antonio Gracias, the longtime Musk associate and DOGE volunteer whose SpaceX stake is now worth around $68 billion — a fortune that traces back, improbably, to franchising Sizzler and Little Caesars before he ever touched a rocket.

I love a good origin story, but the investing lesson here is sobering: $68 billion in one private company is a staggering concentration. It worked spectacularly for him. For the rest of us, the same bet sized wrong is how families lose everything. Diversification is boring precisely because it works.

A-Hed · Americana

The Cattle Killer Comes Back: Texas Ranchers Battle A Flesh-Eating Fly.

A Texas ranch at dawn as an old threat returns.

The New World screwworm — a flesh-eating parasite eradicated from the United States back in the 1960s — is inching north again through Mexico. One turned up on a dog in New Mexico, and Texas ranchers are dusting off control methods their grandfathers used.

A lighter one to end on — but there's a quiet lesson in it. The threats we declare ‘solved’ are the ones that catch us off guard when they drift back. It's true of cattle parasites, and it's true of inflation. Vigilance is cheaper than the cure.

Ideas · The Big Question

Does Microfinance Actually Work? Yunus's Nobel Idea Gets Re-Examined.

A small-business stall in a developing market.

Muhammad Yunus won a Nobel Peace Prize for the idea that tiny loans could be capitalism's cure for global poverty. Two decades on, a wave of randomized controlled trials is asking an uncomfortable question: does it actually lift people out of poverty, or just keep them borrowing?

I bring this up because it's the discipline I try to bring to every ‘sure thing’ in markets too. A beautiful story and a Nobel Prize aren't evidence. Test what you believe against the data, and be willing to be wrong — that's as true for a portfolio as it is for development economics.

Markets · Fixed Income

The Bond Market Isn't Buying The Bounce.

A bond-yield chart on an analyst's screen.

For all the green on the stock screens, the bond market barely budged. The 10-year Treasury yield sat near 4.54% — right where Wednesday's hot inflation print left it. Stocks rallied; bonds shrugged.

When stocks and bonds disagree, I tend to side with the bond market — it's the adult in the room. The message is consistent: rates stay higher for longer, and that keeps a ceiling on the most expensive growth names even on a big up day. I'm letting the bond market set the tone, not the rebound.

Beyond The Markets · Off Duty, Opinion & Your Money